Journal article icon

Journal article

Accumulating evidence suggests anti-TNF therapy needs to be given trial priority in COVID-19 treatment

Publication status:
Published
Peer review status:
Reviewed (other)

Actions


Access Document


Files:
Publisher copy:
10.1016/s2665-9913(20)30309-x

Authors


More by this author
Role:
Author
ORCID:
0000-0002-3156-3418
More by this author
Institution:
University of Oxford
Division:
MSD
Department:
NDORMS
Sub department:
Botnar Research Centre
Oxford college:
St Hilda's College
Role:
Author
ORCID:
0000-0002-8093-7084
Publisher:
Elsevier Publisher's website
Journal:
Lancet Rheumatology Journal website
Volume:
2
Issue:
11
Pages:
e653-e655
Publication date:
2020-09-04
Acceptance date:
2020-09-01
DOI:
EISSN:
2665-9913
Pmid:
33521660
Language:
English
Keywords:
Pubs id:
1135737
Local pid:
pubs:1135737
Deposit date:
2021-08-04

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP